Helmholtz-Zentrum für Infektionsforschung GmbH;Medizinische Hochschule Hannover
发明人:
申请号：
EP11167373.7
公开号：
EP2508607A1
申请日:
2011.05.24
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The present invention relates to the use of a compound which inhibits the activity of MKK4 as a medicament for the treatment of a patient suffering from an impaired liver function, to the use of a compound as a medicament for the treatment of liver failure, including acute/fulminant or chronic liver failure and/or for increasing the regeneration of liver tissue in a patient.
